Mediana

What Mediana does

Mediana (메디아나, KOSDAQ: 041920) is a South Korean medical device manufacturer founded in 1995 and headquartered in Wonju-si, Gangwon-do, with a Seoul business office and wholly-owned US and global subsidiaries. The company designs, manufactures, and distributes patient monitoring devices (M50, M40, M32), vital signs monitors (V20, V10), central monitoring systems (InfowareG and the newer MEDIANA Unified Central), monitor defibrillators (D700, D100), automated external defibrillators (A15, A16 and training units), body composition analyzers (i20/i25, i30/i35, i50/i55), vascular access devices, and the domestically pioneering ACM10 electric CPR machine. Mediana has supplied wired patient monitoring hardware to approximately 3,000 hospitals in Korea — a dominant share of the country's hospital base — and sells through 2,800+ distribution partners across more than 80 countries, with cumulative overseas unit volumes above 700,000.

The company's core technology combines proprietary medical device hardware with AI and software supplied by its parent group Selvas AI (KOSDAQ: 108860) and the Medical AI Strategic Alliance (MASA) partners including Vuno, JLK, EasyCareTech, ATsens, and Furiosa AI. Its flagship platform, MEDIANA Unified Monitoring, integrates wired patient monitors, wearable 14-day continuous ECG patches (via ATsens), and fall detection into a single web-based central monitoring system (MEDIANA Unified Central), which received Korean MFDS digital medical device registration in May 2026. AI capabilities on top of the platform include real-time anomaly detection, predictive analytics for cardiac arrest (Vuno Deepkas) and stroke prognosis (JLK), workflow automation, and an emerging on-premise hospital Sovereign AI stack running on Furiosa AI's RNGD NPU. Mediana holds ISO 13485, CE MDR (first in Korea for AED and PMD CMS), Saudi SFDA, and partner-held FDA and Japan PMDA certifications on the wearable ECG line.

Mediana's revenue model is transitioning from one-time hardware sales toward a mix of device sales plus per-bed subscription contracts for the Unified Monitoring Solution. 2025 consolidated revenue was 648 billion KRW (up 13% YoY) with operating profit of 57 billion KRW (up 339% YoY); Q1 2026 revenue of 161 billion KRW was the highest Q1 in three years. The go-to-market combines direct enterprise field sales, a nationwide Korean distributor network, and global channel partners, with primary customer segments being general hospitals, university hospitals, specialty hospitals (cardiac, rehabilitation, spine/joint, nursing), and emergency medical services. Key reference customers include Baekje General Hospital, Medifield Han River Hospital, National Fire Hospital, Jungjo University Medical Center, and Buchung Nursing Hospital, and the company is actively expanding into Japan (HLB Group/ACA, April 2026) and the Middle East via EasyCareTech's Saudi hospital information system footprint.

Name

Mediana

Legal name

MEDIANA Co., Ltd. (주식회사 메디아나)

Website

https://mediana.co.kr

Company type

Public

Founded year

1995

Operating status

Operating

Headcount range

251–500 employees

Short description

Mediana (메디아나) is a South Korea-based KOSDAQ-listed medical device manufacturer, subsidiary of Selvas AI, supplying patient monitors, AEDs, defibrillators, and the MEDIANA Unified Monitoring AI platform to approximately 3,000 Korean hospitals and 80+ countries.

Ownership category

akta.pro rank

Product category

Medical Devices (Patient Monitoring and Emergency Care)

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration) (HLACAPAI)

akta.pro secondary industries

Connected Medical Devices & Wearables (Sensors, Patches, Implantables) (HLACAPAB), Virtual Nursing, Telemonitoring & Command Center Platforms (HLACAFAH), Data Aggregation, Interoperability & APIs for RPM (FHIR/IoMT Gateways) (HLACAFAO)

Keywords

• Patient monitoring devices
• Automated external defibrillators
• Central monitoring systems
• Medical device manufacturing
• Body composition analyzers

Headquarters

HQ city

Munmak

HQ country

South Korea

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Medical Device Sales: Sales of patient monitoring devices (PMD), automated external defibrillators (AED), monitor defibrillators, and vascular access devices. Includes both wired and wireless product lines. Revenue mix: PMD 47% of sales (76B KRW in Q1 2026), emergency medical solutions 47% (47B KRW in Q1 2026).
2. Unified Monitoring Solution Subscription: Recurring subscription revenue from unified monitoring solutions including wearable ECG monitoring. Contracts typically structured per bed with ongoing service fees. Monthly recurring revenue model targeting 6-700B KRW annually from 15,000 beds (5% of 3,000 hospital network).
3. OEM/ODM Manufacturing: Global partner-focused ODM/OEM business for medical device manufacturing, maintaining stable revenue structure through global medical device companies.
4. Consumables and Accessories: Medical consumables including ECG patches, electrodes, and replacement batteries for wearable devices. Revenue from consumables manufacturing internalization improving profitability.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels5 records

Core offering

Mediana designs, manufactures, and sells medical devices and integrated monitoring solutions for hospitals and healthcare providers, including wired patient monitoring devices (M50, M40, M32), vital signs monitors (V20, V10), automated external defibrillators (A16, A15, T16, T15), monitor defibrillators (D700, D100), the ACM10 electric CPR device, body composition analyzers (i50/i55, i30/i35, i20/i25), vascular access devices, and central monitoring systems (InfowareG, MEDIANA Unified Central). The company is transitioning into an AI-powered healthcare platform through its MEDIANA Unified Monitoring solution, which combines wired monitors, wearable ECG, fall detection, and AI-driven analytics from parent Selvas AI and partners.

Product overview

Mediana is a medical device company that offers a comprehensive portfolio of patient monitoring, emergency medical, and body composition analysis solutions. The core product lines include Patient Monitoring Devices (M50, M40, M32), Vital Signs Monitors (V20, V10), Central Monitoring Systems (InfowareG, Unified Central), Monitor Defibrillators (D700, D100), AEDs (A16, A15, T16, T15), and Body Composition Analyzers (i50/i55, i30/i35, i20/i25). The company is transitioning from a hardware-focused medical device manufacturer to a connected medical and AI healthcare platform company, integrating Selvas AI's software technology. The unified monitoring ecosystem centers on MEDIANA Unified Monitoring platform, which combines wired patient monitors, wireless wearable ECG (via ATsens partnership), and fall detection into a single integrated solution managed through Unified Central CMS. Key strategic products include ACM10 (first domestic electric CPR device) and wearable ECG solutions for continuous patient monitoring.

Differentiator

Problem solved

Functional benefit

Brands

• MEDIANA Unified Monitoring: Integrated monitoring solution combining wired patient monitors, wearable ECG devices, and central monitoring systems.
• MEDIANA Unified Central
• ACM10

Products and services

• Patient Monitoring Device M50 Hospital-grade patient monitoring device measuring ECG, heart rate, SpO2, blood pressure, temperature, and respiration with wireless connectivity capability for bedside patient monitoring.
• Patient Monitoring Device M40 Mid-range patient monitoring device with essential vital signs monitoring capabilities for hospital bed-side applications.
• Patient Monitoring Device M32 Compact patient monitoring device designed for general ward patient monitoring applications.
• Vital Signs Monitor V20 Multi-parameter vital signs monitor for spot-check measurements in hospitals and clinics.
• Vital Signs Monitor V10 Entry-level vital signs monitor for basic patient monitoring needs.
• InfowareG Central Monitoring System Central monitoring system (CMS) software that aggregates patient data from multiple monitoring devices into a centralized nursing station display.
• Veterinary Monitors (M50VET / M40VET) Patient monitoring devices adapted for veterinary use in animal hospitals and clinics.
• MEDIANA Unified Central Next-generation web-based central monitoring system that integrates patient monitoring device and wearable medical device data into a unified management platform. Approved as a digital medical device by Korean MFDS.
• Monitor Defibrillator D700 Advanced monitor defibrillator for emergency medical use with ECG display, defibrillation, and data transmission capabilities.
• Monitor Defibrillator D100 Portable monitor defibrillator designed for emergency response and hospital crash carts.
• Automated External Defibrillator A16 Full-featured AED with semi-automatic and full-automatic operation modes, Biphasic Truncated Exponential waveform, and an optional network connectivity module for remote management.
• Automated External Defibrillator A15 Automated external defibrillator with essential AED functionality for public access and hospital use.
• AED Training Devices (T16 / T15) AED training devices for healthcare provider CPR and AED training.
• ACM10 Electric CPR Device First domestically produced electric automated chest compression (ACC) device in Korea with a belt-fixation compression mechanism and low-center-of-gravity design for stable CPR during patient transport. Received Korean MFDS manufacturing approval.
• Body Composition Analyzer i50 / i55 Professional-grade body composition analyzer for hospitals and healthcare professionals, measuring body fat, muscle mass, and other biometric parameters.
• Body Composition Analyzer i30 / i35 Body composition analyzer for obesity and health management applications.
• Body Composition Analyzer i20 / i25 Essential body composition analyzer with complete solution features for essential monitoring needs.
• Vascular Access Device Vascular access devices including catheters for intravenous therapy and related medical procedures.
• MEDIANA Unified Monitoring Solution Integrated monitoring solution combining wired patient monitors, wireless wearable ECG via the ATsens partnership, and fall detection into a single platform managed through the Unified Central CMS, enabling continuous patient monitoring across beds, wards, and mobile patients.
• Wireless Wearable ECG Monitoring Device Wireless wearable ECG patch (EX871 via the ATsens partnership) for continuous cardiac monitoring with 14-day battery life, FDA/CE/PMDA certifications, and IP57 water resistance for long-term monitoring of ambulatory patients.

Quantifiable outcome

• Unified monitoring solution achieved 1,000 beds in approximately 2 months post-launch
• +3 more outcomes

Named customers7 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration5 records

AI capability6 records

Feature6 records

Partnerships

Nine partnerships are on record, tiered strategic, core and minor.

• XWHY (엑스와이지)strategicStrategic or Co-development Partner · 9 June 2026Physical AI collaboration for medical AI platform expansion, combining patient monitoring devices with physical AI technology.
• JLKcoreStrategic or Co-development Partner · 2 June 2026Medical AI company partnership within MASA for 'Doctor Answer 3.0' government R&D project to build stroke patient prognosis management platform.
• Furyosa AI (퓨리오사AI)strategicStrategic or Co-development Partner · 1 June 2026AI semiconductor partnership for hospital sovereign AI platform. Furyosa AI provides 2nd generation NPU 'RNGD' based medical AI appliance servers for real-time patient data analysis within hospitals.
• HLB Group (Japan)strategicChannel Partner/ Reseller/ Distributor · 29 April 2026Japan market expansion partnership through HLB Group for integrated monitoring solutions targeting 1 million bed market in Japan.
• ACA (Japan)minorChannel Partner/ Reseller/ Distributor · 29 April 2026Japan market expansion partnership for medical AI market targeting.
• MASA (Medical AI Strategic Alliance)coreStrategic or Co-development Partner · 8 April 2026Strategic alliance with Vuno, JLK, and other medical AI companies for AI prediction model development and healthcare AI ecosystem expansion.
• Selvas AIcoreStrategic or Co-development Partner · 23 March 2026Parent company and AI technology provider. Mediana is an affiliate of Selvas AI, combining medical device hardware with Selvas AI's software and AI technology for integrated monitoring solutions. Selvas AI provides AI analysis, voice recognition, and medical AI platform technology.
• EasyCareTech (이지케어텍)coreStrategic or Co-development Partner · 23 March 2026Joint development of AI-based smart ward solution connecting patient monitoring devices, AI analytics, and electronic medical record systems. EasyCareTech provides EMR integration system and user interface, with existing experience supplying hospital information systems to Saudi Arabia.
• ATsens (에이티센스)coreTechnology or Integration · 8 December 2025Wearable ECG technology provider for unified monitoring solutions. ATsens provides wearable diagnostic devices (ECG) with FDA, CE, and Japan PMDA certifications. 14-day continuous ECG patch with water-resistant features.

Scale indicators12 records

Recent moves8 records

Expansion highlights7 records

Broad incumbents

• Philips (Patient Monitoring): Royal Philips operates one of the largest global hospital patient monitoring businesses (IntelliVue, Capsule, acute care platforms). A broad incumbent that competes in the same hospital accounts as Mediana globally, but as part of a much wider medtech portfolio.
• GE HealthCare: Global medtech incumbent with a major patient monitoring franchise (CARESCAPE, ApexPro) and central monitoring offerings. Comparable technology scope but embedded in a much larger imaging and diagnostics portfolio.
• Asahi Kasei (ZOLL Medical): Asahi Kasei owns ZOLL Medical, a global leader in AEDs, defibrillators, and CPR assistance devices. Directly comparable to Mediana's emergency medical and ACM10 electric CPR product lines, but operating as part of a much larger diversified conglomerate.

Direct peers

• Mindray: Chinese global leader in patient monitoring, AEDs, and in-vitro diagnostics. Closest direct peer to Mediana with overlapping product portfolio (multi-parameter patient monitors, AEDs, central monitoring systems) and similar hospital-focused go-to-market across Asia, Europe, and emerging markets.
• Nihon Kohden: Japanese specialist in patient monitoring, ECG, EEG, and clinical information systems. Direct competitor in Asia with deep hospital relationships and a strong ECG/vitals monitoring product line analogous to Mediana's M-series and ATsens-paired wearable ECG strategy.
• Fukuda Denshi: Japanese patient monitoring and ECG specialist with strong hospital penetration in Japan. Direct overlap with Mediana's wired patient monitor and ECG business and a natural comparison point for the HLB Group Japan channel partnership.
• Spacelabs Healthcare: US-based patient monitoring and clinical information systems company (part of OSI Systems). Closely comparable to Mediana in core product scope (wired patient monitors, central monitoring, ambulatory/wireless monitoring) and hospital customer profile.
• Edan Instruments: Chinese medical device manufacturer with comparable patient monitoring, ECG, and AED product lines targeting emerging markets and Asia. Similar scale, product breadth, and emerging-market go-to-market posture to Mediana.
• Schiller AG: Swiss specialist in cardiac monitoring, defibrillation (AED and monitor defibrillators), and patient monitoring. Directly comparable to Mediana's emergency medical and ECG product lines (A16, D700, EX871-class wearable ECG) and similar mid-market global positioning.
• Drägerwerk: German medical and safety technology company with strong hospital patient monitoring, anesthesia, and emergency care portfolios. Comparable in mid-to-high acuity monitoring and integrated care station offerings; major European competitor.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@medianacolin
• LinkedInlinkedin.com/company/mediana-co-ltd/?originalSubdomain=kr

Compliance7 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Mediana